​In March 2020, news outlets in multiple countries began simultaneously reporting that contact lens wearers were at higher risk of COVID-19 infection—claims devoid of scientific proof. Without countermeasures, panic could ensue among the world’s contact lens wearers and health officials, devastating the global contact lens marketplace.

The National Warplane Museum, a grassroots organization with a big name yet limited resources, had a problem. The French government had extended an invitation to fly the Museum’s restored C-47 aircraft (Whiskey 7) from New York to Normandy to participate in D-Day 70th anniversary commemorations. Five months before takeoff, a severe lack of cash placed the mission in jeopardy. Responding to a mayday call, a small group of volunteers—led by McDougall Communications—banded together with Museum staff to bring global attention to the journey.

Verndari first approached McDougall Communications as the COVID pandemic had begun tightening its grip on the world. The Napa, Calif.-based startup suddenly found itself among dozens of companies racing to address the crisis. The early-stage company needed to quickly increase its scientific and brand recognition. 

The challenges of one of the world’s most iconic brands, Eastman Kodak Company, have been well documented. In recent years, the company has transformed its operating model, focusing on advanced materials and chemicals, commercial printing, and the reemergence of film, with a corresponding return to profitability. To help share its turnaround story more broadly among the financial community and customers, Kodak partnered with McDougall Communications to pursue third-party recognition related to its recalibration.It All Begins Here

When nationally renowned entrepreneur Tom Golisano, the founder of Paychex, set out to create a new business school, his team turned to McDougall Communications for help. His vision: Golisano Institute for Business & Entrepreneurship, an accelerated, alternative education model with potential to be a disruptor in higher education. But breaking into a market dominated by established colleges and universities was anything but a sure bet. Within days of sharing his plans and only three weeks before the launch announcement, the agency quickly sprang into action.

As myopia rates surged globally, CooperVision—who developed the first FDA-approved contact lens proven to slow its progression—faced increasing competition and evolving clinical expectations. To maintain leadership, the company expanded its MiSight 1 day portfolio by introducing a silicone hydrogel version and launching the original product in Japan, a key global market.

Corvidia Therapeutics’ lead candidate ziltivekimab was being developed to reduce the risk of major adverse cardiovascular events in chronic kidney disease (CKD) patients with atherosclerotic cardiovascular disease (ASCVD) and inflammation. As the company began preparing for significant financing and clinical milestones, it wanted to leverage these events with key stakeholders.

Facing untapped opportunities in contact lens adoption, the Contact Lens Institute (CLI) partnered with McDougall Communications to better understand patient behaviors and translate those insights into action for eye care professionals (ECPs). Through two major 2025 research efforts—an analysis of digital search behaviors and a large-scale generational survey—CLI uncovered key drivers of contact lens consideration, including a Gen Z usage gap and evolving purchase motivations.

Both Watermark Communities and St. John’s Senior Living offer diverse independent senior living options, aiming to connect with older adults preparing for their next chapter. In a sea of options for senior living (including staying in their homes), both were seeking to stand out. Each chose to partner with McDougall Communications, knowing our creative ideas and extensive connections with Finger Lakes region media and the community would help them reach their goals. 

With millions affected by dry eye disease and limited options to address underlying causes such as eyelid laxity, Lumenis introduced OptiLIFT, a non-invasive solution that uses dynamic muscle stimulation to improve eyelid function and position, closing the gap between conservative care and surgery.